Enzo Biochem, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 79   

Articles published

ENZ 3.00 -0.02 (-0.66%)
price chart
Enzo Biochem, Inc. (NYSE:ENZ) Short Interest Update
Enzo Biochem, Inc. (NYSE:ENZ) ensharesed a drop of 63.1% or -1,336,899 shares in the short positions. The number dropped from 2,117,474 on June 30,2015 to 780,575 on July 15,2015.
3 Life Science Stocks to Sell Now
Enzo Biochem, Inc. (ENZ) is on the decline this week, earning a D (“sell”) after receiving a C (“hold”) last week.
Short Interest Rises For 3 NYSE Stocks: Enzo Biochem, Inc. (NYSE:ENZ), Tremor ...
Enzo Biochem, Inc. (NYSE:ENZ) short interest dropped about -63.1%. According to wsj.com, some 780,575 shares in the stock were short as of 7/15/15, down from 2,117,474 shares on 6/30/15.
Company Shares of Enzo Biochem, Inc. Drops by -3.13%
Enzo Biochem, Inc. (NYSE:ENZ) has dropped 3.13% during the past week, however, the bigger picture is still very bullish; the shares have posted positive gains of 7.27% in the last 4 weeks.
Enzo Biochem, Inc. Short Interest Update
Enzo Biochem, Inc. (NYSE:ENZ) ensharesed a rise of 11.6% or 223,270 shares in the short positions. The number escalated from 1,932,493 on May 29,2015 to 2,155,763 on June 15,2015.
Closing Bell Reports: Enzo Biochem Inc. (ENZ), KBR, Inc. (KBR), Gulfport ...  WallStreet Scope
Short Interest Update of Enzo Biochem, Inc. (NYSE:ENZ)
Enzo Biochem, Inc. (NYSE:ENZ) stated loss of 38,289 shares or 1.8% in the short interest. The short interest registered from 2,155,763 on June 15,2015 to 2,117,474 on June 30,2015.
Enzo Biochem Announces Appointment of James M. O'Brien as Senior VP, Finance
Jim has held leadership positions in the areas of planning and strategic development, financial analysis, SEC reporting and internal controls for both large and small multi-national public companies,” said Barry Weiner, President of Enzo Biochem, Inc ...
Healthcare Stocks Little Changed; Enzo Biochem, Innate Pharma Partnering on ...  NASDAQ
Related articles »  
Enzo Biochem Announces New York State Approval of First FlowScript™ Assay for ...
NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ) today announced that the New York State Department of Health has granted conditional approval for Enzo Clinical Labs' use of the FlowScript™ assay in detection of mRNA from HPV ...
Enzo Biochem's (ENZ) CEO Barry Weiner on Q2 2015 Results -- Earnings ...  Seeking Alpha (registration)
Enzo Biochem, Inc. v. Applera Corp. (Fed. Cir. 2010)
Enzo The '824, '767, '928, and '830 patents, which are owned by Plaintiffs-Appellants Enzo Biochem, Inc., Enzo Life Sciences, Inc., and Yale University ("Enzo"), are directed to various techniques for labeling and detecting nucleic acids. More ...
Enzo Biochem Reaches Patent Infringement Settlement
NEW YORK, Jul 22, 2015 (BUSINESS WIRE) -- Enzo Biochem, Inc. ENZ, -0.66% today announced that it has reached and finalized a settlement with one defendant in an infringement action brought by Enzo regarding its U.S.